Literature DB >> 7144012

[Wegener's granulomatosis: ocular manifestations, diagnosis and therapy].

G Duncker, A Beigel, H Lehmann.   

Abstract

As a chronic, focal, necrotizing granulomatous angiitis Wegener's granulomatosis mainly affects the upper respiratory tract, the lungs and kidneys. Various other organs may be affected including te eyes. Ocular manifestation of Wegener's granulomatosis may result from granulomatous sinusitis that has proceeded into the orbit causing nasolacrimal duct obstruction and proptosis, and affecting eye muscles as well as the optic nerve. Another possible picture is presented by focal vasculitis in the form of conjunctivitis, episcleritis, scleritis, uveitis and granulomatous vasculitis of the retina and optic nerve. In 13 patients out of 26 examined the eyes were found to be involved. The etiology of Wegener's granulomatosis is unknown. The prognosis of this generally lethal disease could definitely be improved by early treatment with cyclophosphamide in combination with glucocorticosteroids.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7144012     DOI: 10.1055/s-2008-1055195

Source DB:  PubMed          Journal:  Klin Monbl Augenheilkd        ISSN: 0023-2165            Impact factor:   0.700


  3 in total

1.  Successful remission induction with a combination therapy of rituximab, cyclophosphamide, and steroids in a patient with refractory optic neuritis in Wegener's granulomatosis.

Authors:  Cord Huchzermeyer; Christian Mardin; Leonard Holbach; Jochen Zwerina; Georg Schett; Jürgen Rech
Journal:  Clin Rheumatol       Date:  2010-09-23       Impact factor: 2.980

2.  Indirect immunofluorescence study of the cornea and the conjunctiva in a xenogeneic system: analysis of humoral reactivity in patients with Wegener's granulomatosis.

Authors:  U Przyklang; B Nölle; E Reinhold-Keller; G Duncker
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1996-02       Impact factor: 3.117

3.  Lacrimal gland enlargement as one of the ocular manifestations of Wegener's granulomatosis.

Authors:  R J Boukes; W A de Vries-Knoppert
Journal:  Doc Ophthalmol       Date:  1985-01-31       Impact factor: 2.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.